Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.
Blood Adv
; 7(16): 4247-4257, 2023 08 22.
Article
in En
| MEDLINE
| ID: mdl-37307173
Full text:
1
Database:
MEDLINE
Main subject:
Neoplasms, Plasma Cell
/
Receptors, Chimeric Antigen
/
Multiple Myeloma
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Blood Adv
Year:
2023
Type:
Article